HomeAI · summaries
Storia in 2 fonti
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage
New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored health insurance may not foot the bill.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Wegovy maker Novo Nordisk pushing for insurers to cover cost of weight loss jabs
Employers and health plans have been reluctant to cover the considerable cost of weight-loss medications
- ·
Hims’ GLP-1 drug business may get a boost as employers drop coverage
About 43% of employers covered the drugs for weight-loss in 2025, and estimates for 2026 are about the same
